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Abstract
Protein identification is one of the major task of Pro-
teomics researchers. Protein identification could be re-
sumed by searching the best match between an experimental
mass spectrum and proteins from a database. Nevertheless
this approach can not be used to identify new proteins or
protein variants. In this paper an evolutionary approach
is proposed to discover new proteins or protein variants
thanks a “de novo sequencing” method. This approach has
been experimented on a specific grid called Grid5000 with
simulated spectra and also real spectra.
1. Introduction
Proteomics can be defined as the global analysis of pro-
teins. Protein identification is one of the major task of Pro-
teomic researchers as it can help to understand the biologi-
cal mechanisms in the living cells. All the current methods
use data from mass-spectrometers and generally give good
results. But in the case of protein variants or new proteins,
these methods can only recognize a protein if it is stored in
a database and can not clearly explain why this protein is
different from any other in the database. The aim of our ap-
proach is to find the entire sequence of a protein, even in the
case of variants or unknown proteins. To do that, we need
to identify the different peptides that composed the protein.
First, their mass (their chemical formula) have to be found
with a MS spectrum and secondly, from their mass, their
sequence can be found with MS/MS spectra. In fact, when
peptides are known, we can obtain the complete protein.
This article is organized as follows. Section 2 deals with
the specificities of protein variants and new protein iden-
tification problems; section 3 describes our approach and
the different algorithms that compose it; section 4 intro-
duces the parallel framework; section 5 presents our results
and discusses them and finally conclusions and perspectives
about this work are provided.
2. The Positioning of the Protein Variants and
New Proteins Identification Problem
The identification of new proteins and protein variants
is a complex problem. All the existing protein identifi-
cation methods are based on two types of data: MS and
MS/MS spectra (MS for Mass Spectrometry) which are
mass/intensity spectra. A MS spectrum is obtained by ex-
traction of an experimental protein from a proteins mix, its
digestion by a specific enzyme and its analysis in a mass
spectrometer. From a MS spectrum, databases allow to
identify all the peptides by their masses. Techniques us-
ing MS spectra for protein identification are identification
methods by peptide mass fingerprint (PMF). The scoring
of these methods is based of the comparison of an exper-
imental peptide mass list with a theoretical peptide mass
list [5, 11]. They give good results but they only find the
closest protein to the experimental one without more infor-
mation. A way to overcome the lacks of MS data is to use
also MS/MS data (tandem mass spectrometry). Each pep-
tide from the MS spectrum is selected and fragmented to
obtain the corresponding MS/MS spectrum. The ions de-
tected are characteristic of the structure of the parent pep-
tide. Thus it is theoretically possible to obtain the sequence
of each peptide from the digested protein. The use of MS
data (mass of the peptides) combined to MS/MS data (par-
tial sequence of the peptides) data increase the accuracy of
the PMF techniques [1, 9]. These scores use several proper-
ties on the ions obtained by MS/MS spectra in order to find
amino acid sequences. With partial amino acid sequences
and masses, proteins can be distinguished easier than with
masses only. However, it is not sufficient to identify un-
known proteins.
An alternative method named de novo sequencing has
been proposed, using tandem mass spectrometry. It works
on random sequence of proteins in order to find the exper-
imental one (without databases). In this case the identifi-
cation is based on random peptides or peptides result of a
earlier identification (made by specific tools) [3, 4, 10, 13].
But the MS/MS data are so fragmented (the deduced se-
quences are limited) and the number of theoretical protein
that can be generated is so large that this kind of technique
is only use on small amount of data. We speak about de
novo peptide sequencing. Furthermore, alignment tools as
Blast are necessary to find the closest peptide corresponding
to the result sequence and validate it.
Evolutionary approaches as optimization method have
been already used against the huge research space of the
de novo peptide sequencing problem [7, 10] and give in-
teresting results. So we have decided to design a genetic
algorithm to make our de novo protein sequencing.
3. General Approach
According to the data available, the number of possible
amino acid sequences is too huge to be enumerated. So a
genetic algorithm (GA) has been chosen for its ability to
explore large solutions space.
Find protein sequences needs two complementary steps:
find the right peptidic masses with MS spectrum and from
them find the corresponding sequences with MS/MS spec-
tra. The first step can be describe as follow: the individuals
(randomly initialized) are digested (theoretical digestion) to
be in a peptides list form and thanks to our evaluation func-
tion our GA can generate individuals that corresponding to
the right peptidic masses list. We will now detailed each of
these parts.
3.1. Digestion Process
The digestion process corresponds to the cleavage of a
protein in smaller residues called peptides. The cleavage
points in the protein depend on the type of the used diges-
tion enzyme because to each enzyme corresponds a cleav-
age grammar. According to the chosen enzyme, the list of
potential peptides is easily obtained. Nevertheless, in the
real process, the enzyme can miss some cleavage points
called miss cleavage. So the number of potential peptides
is greatly increased due to these miss cleavages. We de-
veloped a linear and iterative algorithm which realizes the
theoretical digestion according to the grammar of the en-
zyme chosen and a number of miss cleavage allowed. Our
algorithm works on a two-time basis: first, the peptides are
computed without miss cleavage and then, level by level the
number of miss cleavage is increased until the wanted value.
The digestion process is an essential algorithm for Pro-
teomics approaches. In the next paragraph, we will present
the optimization method.
3.2. The genetic algorithm (GA)
A Genetic Algorithm (GA) works by repeatedly modify-
ing a population of artificial structures through the applica-
tion of genetic operators (crossover and mutation) [8]. The
goal is to find the best possible solution or, at least good, so-
lutions for the problem. Figure 1 shows the global scheme
of a genetic algorithm. Our GA has been developed thanks
to the ParadisEO platform which is a C++ GPL (General
Public Licence) platform made for the conception of evolu-
tionary algorithm [2]. It may allow to find the right peptidic
masses list corresponding to a MS spectrum.
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Figure 1. The general flowchart of a genetic
algorithm. p is the probability of mutation.
• Individuals Representation: the chosen representa-
tion for an individual is a list of peptides for 3 rea-
sons: each individual is digested one time during the
initialization process, the original sequence can be eas-
ily computed; the evaluation function and the fragmen-
tation process need the proteins to be in a peptides
list form. In details an individual is a list of peptides
(with its number of miss cleavage), each peptide is an
amino acid chain and each amino acid can have post-
traductional modifications.
• Evaluation Function: it is a completely original eval-
uation function based on a optimized version of the
algorithm developed by A.L. Rockwood [12] to com-
pute isotopic distributions. The major interest of our
function is a direct comparison of a experimental MS
spectrum with a simulated one. In fact our evaluation
function does not need the mono-isotopic mass list ex-
tracted from the experimental MS spectrum. An in-
dividual of our GA is translated into a chemical for-
mula list. For each chemical formula (so for each pep-
tide), the isotopic distribution is gradually computed
and, peptide by peptide, the simulated spectrum is cal-
culated. The evaluation function computes the corre-
lation between each theoretical peptide and the exper-
imental spectrum. So all the partial score of the the-
oretical peptides correspond to the fitness (the score)
of an individual. However, the evaluation function is
time expensive: a protein of 500 amino acids needs
one second in average to be evaluated.
This evaluation function has been validated by
a research of known proteins in databases. To
make our validation, we use the UNIPROT
database in FASTA format that can be download
at www.expasy.uniprot.org/database/download.shtml.
• Individuals Initialization: this process respects a de
novo sequencing approach. Individuals are randomly
generated according to a variable length (in amino
acids). During the evolution of the GA, the size of indi-
viduals will change thanks to mutation operators (pep-
tide insertion/deletion, amino acids insertion/deletion,
amino acid substitution and post-traductional modifi-
cation mutations). A random generation allows to have
a high diversity of population at the beginning of our
search.
• Operators: they allow a diversified and intensified
search. In a GA, there are two types of operators:
the crossover operator and the mutation operator. The
crossover operator allows to generate “children” indi-
viduals from “parents” individuals. In our case, we use
the well known 1-point crossover operator.
The mutation operator allows to have a genetic diver-
sity in the new individuals. The individuals gener-
ated by crossover can have additional mutation. In
our GA, there are 6 types of mutation: the random
peptide insertion/deletion, the random amino acid in-
sertion/deletion, the amino acid substitution according
a probability from a substitution matrix (by default is
the BLOSUM62 matrix [6]) and the post-traductional
modification. The different mutations have an equal
probability to be selected. All these operators allows
the GA to get very close to the real biological model.
4. A parallel GA
As we have previously noticed, the scoring function
is time expensive. The GA was developed thanks Par-
adisEO [2]. ParadisEO is one of the rare frameworks that
provide the most common parallel and distributed models.
These models concern the island-based running of meta-
heuristics, the evaluation of a population, and the evalua-
tion of a single solution. They are portable on distributed-
memory machines and shared-memory multi-processors as
they are implemented using standard libraries such as MPI,
PVM and PThreads. The models can be exploited in a trans-
parent way, one has just to instantiate their associated Par-
adisEO components.
4.1. Model
As our scoring function is time consuming, we decide
to parallelize the GA by simultaneously evaluating several
individuals. The used model is a master/slave one. The
master sends to slaves individuals to evaluate and the slaves
send back the fitness value. The system is fault tolerant, the
master can detect when a slave is available and send it a
individual thanks a dispatcher.
4.2. Infrastructure
We decide to develop our project on a grid. Grid
computing uses the resources of many separate com-
puters connected by a network (usually the Internet)
to solve large-scale computation problems. We use
Grid5000 (www.grid5000.org) resources for our applica-
tion. Grid5000 has resources located in Lille, Paris-Orsay,
Rennes, Bordeaux, Toulouse, Lyon, Grenoble, Sophia An-
tipolis. Grid5000 uses Renater (the French national network
for research and education) network to connect the different
sites which speed is 2.5 Gbit/s.
5 Results
In this part, we will present the results of the GA and its
parallelization. For all our experiments, the parameters of
our GA have been set to 100 for the population size, 0.9 for
the crossover rate (most used value) and 0.6 for the mutation
rate (experimental value giving the best convergence speed).
5.1. Biological validation
In order to validate our first results, we compare the spec-
trum of our best individual with the simulated one of the
Apo-AI protein.
Figure 2. Apo-AI simulated spectrum vs best
individual spectrum.
On figure 2, we see there a good correlation between the
experimental spectrum and the best individual of our GA.
The most important value is the mass because, for the mo-
ment, all the simulated spectra that we generate have an in-
tensity normalized to 1 (a high intensity only indicates that
more than one peptide have the same mass).
Benchmark Best individual
Proteins Type # Peaks # Peaks # M
Apo-AI Sim 43 58 31
Apo-AI Exp 20 40 9
Cyt-C Sim 16 15 5
Cyt-C Exp 26 48 10
Albu Sim 65 63 15
Table 1. Results gained for several type of
data (Sim for simulated, Exp for experimen-
tal data, M for matches).
Furthermore, Table 1 shows the results obtained with
different types of data: simulated spectra computed from
sequence in FASTA format and experimental spectra from
mass spectrometer. In this table, we remark that results on
simulated data are better than results on experimental data.
It’s due to convergence speed of the GA on simulated data.
So we need to adapt the GA engine (precisely the number
of generations and the stop criterion) to the specificities of
the data. This can be possible when the second step of our
approach will be completely defined.
Table 2 shows that the first of our approach is reached
because we find (globally) the right masses of peptide. Al-
though we have the correct chemical formula, we do not
have necessary the right peptide sequence. But from the
AAI pep δ AAI pep δ
278.153837 9.03 10−5 839.339148 3.93 10−5
347.229445 2.9 10−3 886.474654 2.00 10−5
381.213795 3.2 10−5 899.441563 2.05 10−5
561.263264 7.19 10−5 930.504892 1.07 10−3
603.335367 1.64 10−3 938.432714 9.94 10−4
616.378235 1.7 10−3 948.526690 1.18 10−11
678.393885 1.5 10−3 968.552905 6.25 10−5
804.373937 6.03 10−5 1114.585661 9.72 10−4
817.395676 2.27 10−5 1247.576887 1.11 10−5
830.437206 1.24 10−3 1647.801210 5.60 10−6
Table 2. Matching Apo-AI peptides (AAI pep)
and best individual peptides. δ is the mass
difference, δ= (|Apo-AI peptide - best individ-
ual peptide|/Apo-AI peptide). There are also
11 exact sequence matches which are not
show here.
correct chemical formula and a MS/MS spectrum, we can
extend the evolution of the GA to the right peptide sequence
and so to the right protein sequence (second step for our ap-
proach).
5.2. GA robustness
A genetic algorithm is a stochastic algorithm and each
execution does not always lead to the optimal solution.
Data Max Best Mean Median σ
AAI S 186.54 171.92 163.19 165.14 6.94
AAI E ∅ 63.15 61.30 61.21 1.40
CC S 35.09 29.40 23.75 24.84 3.50
CC E ∅ 93.93 88.07 88.31 4.13
AC S 176.84 170.56 160.99 165.26 9.23
Table 3. Statistics according to the data used.
AAI: Apo-AI Human, CC: Cyt-C Bovin, AC: Al-
bumin Chicken. S/E: simulated/experimental
spectrum. σ: standard deviation.
To study the behavior of the GA we perform 15 experi-
ments (runs of the GA) for each protein. Table 3 summa-
rizes some statistics over the experiments: the optimal fit-
ness (in the case of experimental data, no protein matches
exactly with the spectrum, so no value is given), fitness of
the best individual, mean of the fitness solutions, median
and standard deviation.
Globally, our GA is quite robust on all the data as the
median and the mean are very similar. We remark that we
need to improve the GA to reach optimal value at each time.
5.3. Parallel version
We experiment our parallel version on experimental pro-
teins. We consider that Ts is the time taken to run the fastest
serial algorithm on one processor and Tp is the time taken
by a parallel algorithm on N processors. To measure the
gain of the parallelization, we compute two measures: the
Speed-up = SN= TsTp and the Efficiency =
SN
N
.
Nb Apo-AI Cytc
Proc Time SN Eff Time SN Eff
1 5530 1 1 14712 1 1
4 3430 1.61 0.4 3164 4.65 1.16
8 1641 3.37 0.42 2055 7.16 0.9
16 1215 4.55 0.28 1443 10.2 0.64
32 759 7.29 0.22 1307 11.26 0.35
40 947 5.83 0.14 1020 14.42 0.36
Table 4. Execution time (in sec), Speed-up
(SN ) and Efficiency (Eff) on Grid5000 for 2 ex-
perimental spectra according to the number
of processors (Nb Proc).
Table 4 summarizes values of the two measures for the
Apo-AI and Cytc proteins. We can observe that for Apo-
AI the efficiency is less than 1 for any number of proces-
sors and is very bad for more than 32 processors whereas
for Cytc we can observe supra linear performance. The
reasons of such an observation can be due to load balanc-
ing (Grid5000 is an heterogeneous grid); a communication
overhead or the potentially volatile nodes (Grid5000 is com-
pound of PC clusters from university that could be poten-
tially used by students or be turned off).
6. Conclusions and Perspectives
In this article a genetic algorithm has been proposed to
discover the sequence of an experimental protein. We have
explained the limits of the current methods and the inter-
est of a GA. The novelties of our approach are our evalu-
ation function and the application of a de novo sequencing
method on complete proteins and not only on small pep-
tides. Furthermore, we have experimented a parallel version
of our GA on a Grid. A lot of work remains to increase the
potential of the approach and the performance of the GA
in order to find the right peptide sequences that compound
the experimental protein. We will continue to work on our
evaluation function in order to find new ones and manage to
combine some of them in order to have better quality solu-
tions.
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